TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharem Biotech AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
303
|
151
|
50 |
| Financial expenses |
47
|
21
|
3 |
| Earnings before taxes |
-414
|
-691
|
-617 |
| EBITDA |
95
|
-197
|
-94 |
| Total assets |
1,524
|
2,005
|
3,401 |
| Current assets |
610
|
634
|
1,393 |
| Current liabilities |
892
|
783
|
943 |
| Equity capital |
631
|
765
|
1,585 |
| - share capital |
10
|
9
|
10 |
| Employees (average) |
5
|
5
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
41.4%
|
38.2%
|
46.6% |
| Turnover per employee |
61
|
30
|
17 |
| Profit as a percentage of turnover |
-136.6%
|
-457.6%
|
-1234.0% |
| Return on assets (ROA) |
-24.1%
|
-33.4%
|
-18.1% |
| Current ratio |
68.4%
|
81.0%
|
147.7% |
| Return on equity (ROE) |
-65.6%
|
-90.3%
|
-38.9% |
| Change turnover |
151
|
105
|
-36 |
| Change turnover % |
100%
|
226%
|
-41% |
| Chg. No. of employees |
0
|
2
|
-2 |
| Chg. No. of employees % |
0%
|
67%
|
-40% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.